Opsonix's Series A Round

Opsonix raised a round of funding on October 08, 2015.

Opsonix is developing pathogen-extracting therapies to transform the treatment of blood borne infectious diseases, including sepsis. The company's proprietary expertise is creating engineered pathogen…

Articles about Opsonix's Series A Round: